يعرض 1 - 10 نتائج من 42 نتيجة بحث عن '"Rodriguez-Freixinos, Victor"', وقت الاستعلام: 0.90s تنقيح النتائج
  1. 1
    رسالة جامعية

    المؤلفون: Rodríguez Freixinós, Víctor

    المساهمون: University/Department: Universitat Autònoma de Barcelona. Departament de Medicina

    مرشدي الرسالة: Giralt López de Sagredo, Jorge Luis, Prat Aparicio, Aleix

    المصدر: TDX (Tesis Doctorals en Xarxa)

    وصف الملف: application/pdf

  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Poveda A Oncogynecologic Department, Initia Oncology, Hospital Quironsalud Valencia, Avda Blasco Ibañez, 14, 46 010 Valencia, Spain. Oaknin A, Fariñas-Madrid L Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Romero I, Guerrero-Zotano A Department of Medical Oncology, Fundación Instituto Valenciano de Oncología (IVO), Valencia, Spain. Rodriguez-Freixinos V Department of Medical Oncology and Hematology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Scientific Reports;11; https://doi.org/10.1038/s41598-021-82671-wTest; Poveda A, Oaknin A, Romero I, Guerrero-Zotano A, Fariñas-Madrid L, Rodriguez-Freixinos V, et al. A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors. Sci Rep. 2021 Dec 24;11:4433.; https://hdl.handle.net/11351/5965Test; 000626806200025

  4. 4
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Rodriguez-Freixinos V, Fariñas-Madrid L, Oaknin A Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Gynecological Malignancies Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Ruiz-Pace F, Villacampa G Oncology Data Science - Prescreening Molecular, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Garrido-Castro AC Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Nuciforo P Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vivancos A Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Dienstmann R Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Oncology Data Science - Prescreening Molecular, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: ESMO Open;4(2); https://www.esmoopen.com/article/S2059-7029Test(20)30169-1/fulltext; Rodriguez-Freixinos V, Ruiz-Pace F, Fariñas-Madrid L, Garrido-Castro AC, Villacampa G, Nuciforo P, et al. Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancer. ESMO Open. 2019 Mar 8;4(2):e000444.; https://hdl.handle.net/11351/5768Test; 000468581300005

  8. 8
    دورية أكاديمية

    المساهمون: Rodriguez-Freixinos, Víctor, Capdevila, Jaume, Pavel, Marianne, Thawer, Alia, Baudin, Eric, O'Toole, Dermot, Herrmann, Ken, Welin, Staffan, Grozinsky-Glasberg, Simona, de Herder, Wouter W, Valle, Juan W, Herman, Jackie, Kolarova, Teodora, Bouvier, Catherine, Falconi, Massimo, Ferone, Diego, Singh, Simron

    العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000610215700020; volume:144; firstpage:200-214; lastpage:214; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/20.500.11768/109037Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85098738559

  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية